- Non-invasive ultra-rapid test delivers 98% sensitivity and 100% specificity in symptomatic and asymptomatic individuals with SARS-CoV-2 including variants
- Designed for point-of-care (POC) diagnosis, ease of use and rapid mass-screening, the digital platform enables efficient track & trace and has potential to open up the economy













